Medicated Skin Care in Spain

May 2012 | 38 pages | ID: M214A8B606DEN
Euromonitor International Ltd

Abstracts

The poor economic conditions experienced in Spain are clearly affecting sales of medicated skin care as they did the rest of Spanish consumer health. Moreover in Spain, in 2011 the number of families with all their members unemployed reached 1,386,000. This fact placed even more pressure on the family budget as traditionally it has been the family network that has absorbed impact of unemployment distress in Spain, as although one member may be unemployed the economic needs of the family unit...

Euromonitor International's Medicated Skin Care in Spain report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2007-2011, allowing you to identify the sectors driving growth. Forecasts to 2016 illustrate how the market is set to change.

Product coverage: Antiparasitics/Lice (Head and Body) Treatments, Antipruritics, Cold Sore Treatments, Haemorrhoid Treatments, Hair Loss Treatments, Medicated Shampoos, Nappy (Diaper) Rash Treatments, Paediatric Medicated Skin Care, Topical Allergy Remedies/Antihistamines, Topical Antifungals, Topical Germicidals/Antiseptics, Vaginal Antifungals.

Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.

Why buy this report?

• Get a detailed picture of the Medicated Skin Care market;
• Pinpoint growth sectors and identify factors driving change;
• Understand the competitive environment, the market’s major players and leading brands;
• Use five-year forecasts to assess how the market is predicted to develop.

Euromonitor International has over 40 years' experience of publishing market research reports, business reference books and online information systems. With offices in London, Chicago, Singapore, Shanghai, Vilnius, Dubai, Cape Town, Santiago, Sydney, Tokyo and Bangalore and a network of over 800 analysts worldwide, Euromonitor International has a unique capability to develop reliable information resources to help drive informed strategic planning.

Contents

Headlines
Trends
Switches
Competitive Landscape
Prospects
Category Data
  Table 1 Sales of Medicated Skin Care by Category: Value 2006-2011
  Table 2 Sales of Medicated Skin Care by Category: % Value Growth 2006-2011
  Table 3 Medicated Skin Care Company Shares by Value 2007-2011
  Table 4 Medicated Skin Care Brand Shares by Value 2008-2011
  Table 5 Hair Loss Treatments Brand Shares by Value 2008-2011
  Table 6 Forecast Sales of Medicated Skin Care by Category: Value 2011-2016
  Table 7 Forecast Sales of Medicated Skin Care by Category: % Value Growth 2011-2016
Almirall Prodesfarma SA in Consumer Health (spain)
Strategic Direction
Key Facts
  Summary 1 Almirall Prodesfarma SA: Key Facts
  Summary 2 Almirall Prodesfarma: Operational Indicators
Company Background
Production
Competitive Positioning
  Summary 3 Almirall Prodesfarma SA: Competitive Position 2011
Bayer Hispania SA in Consumer Health (spain)
Strategic Direction
Key Facts
  Summary 4 Bayer Hispania SA: Key Facts
Company Background
Production
Competitive Positioning
  Summary 5 Bayer Hispania SA: Competitive Position 2011
Esteve SA in Consumer Health (spain)
Strategic Direction
Key Facts
  Summary 6 Esteve SA: Key Facts
  Summary 7 Esteve SA: Operational Indicators
Company Background
Production
Competitive Positioning
  Summary 8 Esteve SA: Competitive Position 2011
Laboratorios Viñas SA in Consumer Health (spain)
Strategic Direction
Key Facts
  Summary 9 Laboratorios Viñas SA: Key Facts
Company Background
Production
Competitive Positioning
  Summary 10 Laboratorios Viñas SA: Competitive Position 2011
Mcneil Iberica Slu in Consumer Health (spain)
Strategic Direction
Key Facts
  Summary 11 McNeil Iberica SLU: Key Facts
Company Background
Production
Competitive Positioning
  Summary 12 McNeil Iberica SLU: Competitive Position 2011
Novartis Farmaceutica SA in Consumer Health (spain)
Strategic Direction
Key Facts
  Summary 13 Novartis Farmaceutica SA: Key Facts
Company Background
Production
Competitive Positioning
  Summary 14 Novartis Consumer Health SA: Competitive Position 2011
Uriach-aquilea OTC Sl in Consumer Health (spain)
Strategic Direction
Key Facts
  Summary 15 Uriach-Aquilea OTC SL: Key Facts
  Summary 16 Uriach-Aquilea OTC SL: Operational Indicators
Company Background
Production
Competitive Positioning
  Summary 17 Uriach-Aquilea OTC SL: Competitive Position 2011
Executive Summary
Economy Fears A New Recession
New Laws in the Pipeline
Mcneil Retains Leadership of Consumer Health
Grocery Retailers Consolidate Trends
Slow Movement Going Forward
Key Trends and Developments
Economy Fears A New Recession
New Laws in the Pipeline
Climate Shapes Sales
Spanish Population
the Silent Pandemic
Market Indicators
  Table 8 Consumer Expenditure on Health Goods and Medical Services 2006-2011
  Table 9 Life Expectancy at Birth 2006-2011
Market Data
  Table 10 Sales of Consumer Health by Category: Value 2006-2011
  Table 11 Sales of Consumer Health by Category: % Value Growth 2006-2011
  Table 12 Consumer Health Company Shares 2007-2011
  Table 13 Consumer Health Brand Shares 2008-2011
  Table 14 Penetration of Private Label by Category 2006-2011
  Table 15 Sales of Consumer Health by Distribution Format: % Analysis 2006-2011
  Table 16 Sales of Consumer Health by Category and Distribution Format: % Analysis 2011
  Table 17 Forecast Sales of Consumer Health by Category: Value 2011-2016
  Table 18 Forecast Sales of Consumer Health by Category: % Value Growth 2011-2016
Appendix
OTC Registration and Classification
Consumer Health Registration and Classification
Advertising
Packaging and Labelling
Waste
Distribution
Groups and Associations for Pharmacists Grow
De-listing Or De-reimbursement
Vitamins and Dietary Supplements Registration and Classification
Retail Distribution
Alternative Therapy
Homoeopathic Medicines
Self-medication/self-care and Preventative Medicine
Switches
Definitions
Sources
  Summary 18 Research Sources